Southern Acids (M) BhdXKLS:5134 73 Altman Z-Score is 4.45 as of Jul. 06, 2026, which is 20% below its 10-year median of 5.53. GuruFocus rates XKLS:5134 with a GF Score™ of 73/100 and a GF Value™ of RM2.89 (Fairly Valued). The stock has 3 warning signs investors should review. Among 549 Conglomerates companies, Southern Acids (M) Bhd ranks better than 83.79% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 4.45 is strong.
Southern Acids (M) Bhd has a Altman Z-Score of 4.45, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Southern Acids (M) Bhd's Altman Z-Score or its related term are showing as below:
XKLS:5134'
s Altman Z-Score Range Over the Past 10 Years
Min: 4.35 Med: 5.53 Max: 6.41
Current: 4.45
During the past 13 years, Southern Acids (M) Bhd's highest Altman Z-Score was 6.41. The lowest was 4.35. And the median was 5.53.
Southern Acids (M) Bhd (XKLS:5134) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Southern Acids (M) Bhd Altman Z-Score Related Terms
Southern Acids (M) Bhd Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Southern Acids (M) Bhd's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Southern Acids (M) Bhd's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Southern Acids (M) Bhd Altman Z-Score vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Southern Acids (M) Bhd's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Southern Acids (M) Bhd's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Southern Acids (M) Bhd (XKLS:5134) has a Altman Z-Score of 4.45 as of Jul. 06, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Southern Acids (M) Bhd and its competitors. This is 20% below median its historical median of 5.53. Over the past decade, Southern Acids (M) Bhd's Altman Z-Score has ranged from 4.35 to 6.41. According to the industry distribution chart, Southern Acids (M) Bhd ranks #89 out of 549 companies in the Conglomerates industry, placing it in the top 16.2%.
Is Southern Acids (M) Bhd's Altman Z-Score too high?
Southern Acids (M) Bhd's current Altman Z-Score of 4.45 is 20% below median its 10-year median of 5.53. Over the past 10 years, this metric has ranged from a low of 4.35 to a high of 6.41. The Conglomerates industry median Altman Z-Score is 2.07. Southern Acids (M) Bhd's value of 4.45 is 115% above this industry median. Based on the distribution chart, Southern Acids (M) Bhd ranks #89 out of 549 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, Southern Acids (M) Bhd has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's Altman Z-Score compare to HON and MMM?
According to the Conglomerates industry distribution chart, Southern Acids (M) Bhd ranks #89 out of 549 companies for Altman Z-Score. This places Southern Acids (M) Bhd in the top 16% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.07. Southern Acids (M) Bhd's value of 4.45 is 115% above this benchmark. Historically, Southern Acids (M) Bhd's own Altman Z-Score has ranged from 4.35 to 6.41 over the past decade. While the company's 10-year median is 5.53 vs. the industry median of 2.07, Southern Acids (M) Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Conglomerates company?
The median Altman Z-Score among Conglomerates companies is 2.07, based on 549 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Southern Acids (M) Bhd's current Altman Z-Score of 4.45 is 115% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Southern Acids (M) Bhd and its competitors. For the Conglomerates industry, the median Altman Z-Score is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Southern Acids (M) Bhd's current Altman Z-Score is 4.45, which is 20% below median its own 10-year median of 5.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.89, compared to a current price of RM3.03 — trading 4.8% above its estimated fair value. The current Altman Z-Score is 4.45, which is 20% below median its 10-year median of 5.53 and 115% above the Conglomerates industry median of 2.07. Southern Acids (M) Bhd's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current Altman Z-Score is 4.45 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?
Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued.
The current stock price of RM3.03 is trading 4.8% above its estimated GF Value™ of RM2.89.
GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.
Key valuation signals for XKLS:5134:
Altman Z-Score: 4.45 (20% below median its 10-year median of 5.53)
GF Value™: RM2.89 vs. price of RM3.03 (4.8% above fair value)
Industry Position: 115% above the Conglomerates median (#89 of 549)
No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
73GF Score
Get the complete analysis for XKLS:5134
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5134 has been successfully added to your 
